Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium - PubMed (original) (raw)
Clinical Trial
doi: 10.1002/ccd.20406.
Affiliations
- PMID: 15954106
- DOI: 10.1002/ccd.20406
Clinical Trial
Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium
Demosthenes G Katritsis et al. Catheter Cardiovasc Interv. 2005 Jul.
Abstract
The aim of the study was to investigate whether a combination of mesenchymal stem cells (MSCs) capable of differentiating into cardiac myocytes and endothelial progenitors (EPCs) that mainly promote neoangiogenesis might be able to facilitate tissue repair in myocardial scars. Previous studies have shown that intracoronary transplantation of autologous bone marrow stem cells results in improvement of contractility in infracted areas of human myocardium. Eleven patients with an anteroseptal myocardial infarction (MI) underwent transcoronary transplantation of bone marrow-derived MSCs and EPCs to the infarcted area through the left anterior descending artery. Eleven age- and sex-matched patients served as controls. Wall motion score index was significantly lower at follow-up in the transplantation (P = 0.04) but not in the control group. On stress echocardiography, there was improvement of myocardial contractility in one or more previously nonviable myocardial segments in 5 out of 11 patients (all with recent infarctions) and in none of the controls (P = 0.01). Restoration of uptake of Tc(99m) sestamibi in one or more previously nonviable myocardial scars was seen in 6 out of 11 patients subjected to transplantation and in none of the controls (P = 0.02). Cell transplantation was an independent predictor of improvement of nonviable tissue. Intracoronary transplantation of MSCs and EPCs is feasible, safe, and may contribute to regional regeneration of myocardial tissue early or late following MI.
Similar articles
- A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery.
Yang Z, Zhang F, Ma W, Chen B, Zhou F, Xu Z, Zhang Y, Zhang D, Zhu T, Wang L, Wang H, Ding Z, Zhang Y. Yang Z, et al. Cardiovasc Ther. 2010 Dec;28(6):380-5. doi: 10.1111/j.1755-5922.2009.00116.x. Cardiovasc Ther. 2010. PMID: 20337639 Clinical Trial. - The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction.
Nassiri SM, Khaki Z, Soleimani M, Ahmadi SH, Jahanzad I, Rabbani S, Sahebjam M, Ardalan FA, Fathollahi MS. Nassiri SM, et al. J Biomed Sci. 2007 Nov;14(6):745-55. doi: 10.1007/s11373-007-9188-9. Epub 2007 Jul 1. J Biomed Sci. 2007. PMID: 17605008 - Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
Yang ZJ, Ma DC, Wang W, Xu SL, Zhang YQ, Chen B, Zhou F, Zhu TB, Wang LS, Xu ZQ, Zhang FM, Cao KJ, Ma WZ. Yang ZJ, et al. Gene Ther. 2006 Nov;13(22):1564-8. doi: 10.1038/sj.gt.3302820. Epub 2006 Jun 29. Gene Ther. 2006. PMID: 16810195 - Stem cell research and cell transplantation for myocardial regeneration.
Siepe M, Heilmann C, von Samson P, Menasché P, Beyersdorf F. Siepe M, et al. Eur J Cardiothorac Surg. 2005 Aug;28(2):318-24. doi: 10.1016/j.ejcts.2005.03.044. Eur J Cardiothorac Surg. 2005. PMID: 15939610 Review. - [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].
Schannwell CM. Schannwell CM. Dtsch Med Wochenschr. 2008 Dec;133 Suppl 8:S274-9. doi: 10.1055/s-0028-1100961. Epub 2008 Dec 15. Dtsch Med Wochenschr. 2008. PMID: 19085806 Review. German.
Cited by
- Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis.
Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Jeevanantham V, et al. Circulation. 2012 Jul 31;126(5):551-68. doi: 10.1161/CIRCULATIONAHA.111.086074. Epub 2012 Jun 22. Circulation. 2012. PMID: 22730444 Free PMC article. Review. - Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, George R, Lardo A. Hare JM, et al. JAMA. 2012 Dec 12;308(22):2369-79. doi: 10.1001/jama.2012.25321. JAMA. 2012. PMID: 23117550 Free PMC article. Clinical Trial. - Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review.
Alvarez PA, Schwarz ER, Ramineni R, Myatt P, Barbin C, Boissonnet C, Phan A, Maggioni A, Barbagelata A. Alvarez PA, et al. Clin Res Cardiol. 2013 Jan;102(1):1-10. doi: 10.1007/s00392-012-0508-3. Epub 2012 Sep 28. Clin Res Cardiol. 2013. PMID: 23052331 Review. - Current status of stem cell therapy in heart failure.
Codina M, Elser J, Margulies KB. Codina M, et al. Curr Cardiol Rep. 2010 May;12(3):199-208. doi: 10.1007/s11886-010-0098-5. Curr Cardiol Rep. 2010. PMID: 20424962 Free PMC article. Review. - Evaluation of the potentials of autologous blood injection for healing in diabetic foot ulcers.
Al Azrak M, Ismail T, Shaker O. Al Azrak M, et al. J Am Coll Clin Wound Spec. 2013 Jul 12;4(2):45-50. doi: 10.1016/j.jccw.2013.06.006. eCollection 2012 Jun. J Am Coll Clin Wound Spec. 2013. PMID: 24527383 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical